Giovanni Martinelli
IRST IRCCS · University of Bologna · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS , Meldola Italy
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
20
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
190
PubMed author-name match
Trials
Studies that name Giovanni Martinelli as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:52 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06919393 · "Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALLIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · recruiting · Leukemia, Lymphoblastic · study director
- Ph3NCT06713837 · IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · recruiting · Acute Myeloid Leukemia, Relapse/Recurrence · study chair
- N/ANCT06459024 · Master Framework For Relapse or Refractory Acute Myeloid LeukemiaIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · recruiting · Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory · study chair
- Ph2NCT04363827 · Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · terminated · COVID19, Hydroxychloroquine, Prophylaxis · study chair
- N/ANCT04345315 · Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · unknown · COVID-19, SARS-CoV-2 · principal investigator
- N/ANCT04298892 · Integrated Multiomics and Multilevel Characterization of Haematological Disorders and MalignanciesIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · unknown · Haematologic Disease, Haematological Malignancy · study director
- N/ANCT04070807 · Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · unknown · Acute Myeloid Leukemia · principal investigator
- N/ANCT03898128 · ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 ImmunoconjugateIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · completed · Acute Lymphoblastic Leukemia · study director
- N/ANCT03789981 · Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid LeukemiaIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · unknown · Acute Myeloid Leukemia · study chair
- Ph2NCT03610438 · Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic LeukemiaGruppo Italiano Malattie EMatologiche dell'Adulto · active not recruiting · Acute Lymphoid Leukemia · study chair
- N/ANCT03547258 · Italian Non-Interventional Study of FLT3 Mutated AML PatientsIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · unknown · AML, FLT3-ITD Mutation, FLT3-TKD Mutation · study chair
- Ph2NCT03455504 · Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid LeukemiaGruppo Italiano Malattie EMatologiche dell'Adulto · completed · Acute Myeloid Leukemia · study chair
- N/ANCT02986620 · Italian Registry on the Prevalence of IDH1/IDH2 Mutations in Patients With Acute Myeloid LeukemiaGruppo Italiano Malattie EMatologiche dell'Adulto · completed · AML, Adult · study chair
- Ph2NCT01446900 · R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic LymphomaEuropean Institute of Oncology · terminated · Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma · study chair
- N/ANCT00961285 · Genotyping Analysis of Acute Lymphoblastic LeukemiaUniversity of Bologna · unknown · Acute Lymphoblastic Leukemia, Adult · principal investigator
- Ph4NCT00797810 · Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in AdultsUniversity of Bologna · unknown · Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma · principal investigator
- N/ANCT00544219 · PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneSwiss Cancer Institute · completed · Lymphoma · study chair
- Ph2NCT00510939 · Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid LeukemiaUniversity of Bologna · unknown · Acute Myeloid Leukemia · principal investigator
- Ph2NCT00511069 · Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ LeukemiaUniversity of Bologna · completed · Leukemia · principal investigator
- Ph3NCT00210353 · Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT LymphomaInternational Extranodal Lymphoma Study Group (IELSG) · completed · Lymphoma, Mucosa-Associated Lymphoid Tissue · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:52 UTC. The ranking covers the 200 most relevant of 190 PubMed records, and a shared surname and initials can bring in a namesake. All 190 on PubMed
- 1,127 citationsRCR 36.3
- Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.N Engl J Med · 20191,106 citationsRCR 41.3
- 1,005 citationsRCR 29.4
- Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.Circulation · 2006765 citationsRCR 17.6
- Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.N Engl J Med · 2005479 citationsRCR 11.7
- 457 citationsRCR 9.7
- Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.Lancet Oncol · 2017427 citationsRCR 14.2
- 409 citationsRCR 14.2
- 380 citationsRCR 8.9
- 365 citationsRCR 11.0